Skip to main content
. 2021 Mar 22;21:159. doi: 10.1186/s12893-021-01170-x

Table 4.

Patients offered primary SLNB according to final pathology and breast surgery type

BCS (n = 145) TM (n = 162)
DCIS Invasive cancer DCIS Invasive cancer
SLNB (n = 202) 38 16 107 41
No SLNB (n = 105) 89 2 14 0
127 (87.6%) 18 (12.4%) 121 (74.7%) 41 (25.3%)

BCS breast-conserving surgery, DCIS ductal carcinoma in situ, SLNB sentinel lymph node biopsy, TM total mastectomy